Thirty-year Study Reshapes Understanding Of How Women Age
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

The Study of Women’s Health Across the Nation (SWAN), launched in the mid-1990s, has received the first installment of a $44.4 million, five-year NIH award. Researchers will continue following more than 3,000 participants into their 70s and beyond, examining links between menopause, physical health, brain health and well-being.

The Study of Women’s Health Across the Nation (SWAN) has received the first installment of a $44.4 million, five-year National Institutes of Health award, allowing researchers to continue following more than 3,000 women into their 70s and beyond. The long-running U.S. study will examine how menopause and midlife experiences relate to women’s later physical, cognitive and mental health.

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

Launched in the mid-1990s, SWAN began by studying hormonal changes and symptoms during the menopausal transition. Researchers have since followed the same participants over time, creating a record that can help them investigate how health changes across midlife and into older age. The study includes women from different racial and ethnic groups and varied social and economic backgrounds.

The new funding supports a further five years of follow-up at seven designated research sites, with coordination based at the University of Pittsburgh. Planned work includes adding brain MRI scans to a cardiovascular project, examining cerebrovascular disease and stroke risk, and studying bone density and tiny fractures through spine X-rays. Researchers will also measure hormone levels, assess physical function and explore experiences including loneliness, social frailty and sense of purpose.

The participating sites include the University of Pittsburgh, Massachusetts General Hospital, the University of Michigan, University of California Davis/Kaiser Permanente, University of California at Los Angeles, Albert Einstein College of Medicine and Rush University Medical Center. The source report says the award totals $44.4 million and that its first installment arrived in September; it does not specify the installment amount.

At a glance
reportWhen: First installment received in September…
The developmentThe NIH has begun a new five-year funding period for SWAN, extending a 30-plus-year study of women’s health through aging.

Following Health From Midlife Onward

Many studies of older adults begin observing people after they have already reached older age. SWAN’s repeated measurements, taken over decades, give researchers a chance to compare later health with information recorded earlier in participants’ lives. That may help identify patterns associated with better physical function, mental health or quality of life, although the study design alone does not establish that menopause causes a later condition.

The additional brain imaging and assessments broaden the research beyond its early emphasis on hormones and menopause symptoms. By examining brain and cardiovascular measures alongside bone health, mobility and social experiences, the project can investigate how these dimensions of aging relate to one another. Findings could inform future research and discussions among clinicians and patients, but the source report does not describe new results or clinical recommendations from this funding announcement.

Products Worth Considering

Hyperice Hypervolt 3 Percussion Massage Gun with Heated Head and Carry Case

Hyperice Hypervolt 3 Percussion Massage Gun with Heated Head and Carry Case

As an affiliate, we earn on qualifying purchases.

From Menopause Symptoms to Aging

SWAN was established to study a transitional period in women’s health: the years surrounding menopause. Its initial focus included endocrinology and symptoms. Because investigators have continued to follow participants, the study has grown into a more than 30-year investigation of menopause, brain and physical health, and well-being.

Rush University’s site was initially called the Women in the Southside Health Project, reflecting its focus on the Chicago communities of Beverly, Morgan Park and Washington Heights. The broader study now involves seven research sites and a coordinating center. Its continuing work is intended to examine how midlife may relate to health and quality of life later on, rather than treating menopause as an isolated event.

“And now the question is how do these changes impact health and well-being later in life?”

— Imke Janssen, PhD, professor in the Department of Family and Preventive Medicine at Rush

Questions the New Phase Will Test

The funding announcement describes planned research, not findings from the new phase. It does not provide results linking menopause to later stroke, brain changes, fractures or mental health outcomes, and it does not establish that menopause directly causes any such outcomes. The size and direction of any relationships remain to be studied.

The report also does not give a detailed timeline for individual projects, explain how many participants are expected to complete each assessment, or state when results will be published. Although the award totals $44.4 million over five years, the amount of the September installment is not specified.

Five More Years of Follow-Up

Researchers at the seven sites will continue contacting and assessing participants who joined SWAN in the mid-1990s. The planned work includes brain MRI, spine imaging, hormone testing and physical-function assessments, alongside questions about social connection and life purpose. Those measurements will be used to investigate how health and well-being change with age.

The next public milestones are likely to include study updates and results from the projects funded in this five-year period. The source report does not give publication dates or a schedule for releasing findings. Until those analyses are available, the study’s planned measures should be understood as research questions, not evidence that a particular outcome has been established.

Key Questions

What is the SWAN study?

SWAN is a U.S. longitudinal study that has followed women since the mid-1990s to investigate the menopausal transition and health as participants age.

How many women are being followed?

The study is continuing to follow more than 3,000 participants, who are expected to be tracked into their 70s and beyond.

What will researchers measure in the new phase?

Planned assessments include brain MRI scans, spine X-rays, hormone levels and physical function. Researchers will also examine areas such as loneliness, social frailty and sense of purpose.

Has the study shown that menopause causes later health problems?

No new causal finding is reported in the funding announcement. The research will examine how menopause-related changes relate to later health; the relationships and their causes remain under study.

How is the next phase funded?

The NIH has awarded a total of $44.4 million over five years. The report says the first installment arrived in September but does not state its amount.

Source: news-medical.net

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Multi-component Nutritional Supplement Improves Markers Of Vascular Health

A six-month randomized trial of NOVOS Core found changes in vascular health markers, but did not test whether the supplement prevents heart attacks or strokes.

Chrissy Metz Weight Loss

Actress Chrissy Metz confirms she has lost weight, citing health and wellness reasons. Details on her journey and future plans remain limited.

Denture Care Mistakes Your Dentist Wishes You’d Stop Making

One common mistake is using harsh cleaning products like bleach or abrasive…

Dr Fauci

Dr. Anthony Fauci testified before Congress regarding the COVID-19 pandemic, providing updates on the virus and public health measures. The hearing is ongoing.